Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01365728 · ClinicalTrials.gov registry record

An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness

A clinical trial of Myopia and Astigmatism, sponsored by Stanford University.

Completed
Registry status
61
Enrollment target
1
Study location

NCT01365728 is a study of Myopia and Astigmatism that has completed, run by Stanford University. The registered enrollment target is 61 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01365728, a study of Myopia and Astigmatism, has completed, sponsored by Stanford University.

COMPLETED
Registry status
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to compare the results of LASIK surgery when using two versions of a femtosecond laser in patients with nearsightedness with and without astigmatism.

Conditions Studied

Interventions

  • PROCEDURE LASIK with the iFS femtosecond laser

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2011-04
Est. Completion 2018-12

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01365728

The ClinicalTrials.gov registry entry for NCT01365728 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (77% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which LASIK with the iFS femtosecond laser is the first listed.

NCT01365728 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01365728 about?

NCT01365728 is a clinical study titled "An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness". The purpose of the study is to compare the results of LASIK surgery when using two versions of a femtosecond laser in patients with nearsightedness with and without astigmatism.

What is the current status of trial NCT01365728?

This trial is currently completed. The enrollment target is 61 participants. The study started on 2011-04. Estimated completion is 2018-12.

What conditions does trial NCT01365728 study?

This clinical trial studies the following conditions: Myopia, Astigmatism.

What interventions are being tested in trial NCT01365728?

The interventions under investigation include: LASIK with the iFS femtosecond laser (PROCEDURE).

Who is sponsoring clinical trial NCT01365728?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01365728 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.